Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1994 Sep;57(9):1091–1094. doi: 10.1136/jnnp.57.9.1091

Accidental transmission of Creutzfeldt-Jakob disease by dural cadaveric grafts.

J F Martínez-Lage 1, M Poza 1, J Sola 1, J G Tortosa 1, P Brown 1, L Cervenáková 1, J A Esteban 1, A Mendoza 1
PMCID: PMC1073134  PMID: 8089676

Abstract

Four patients who received dural grafts of cadaveric origin in the course of posterior fossa procedures subsequently developed Creutzfeldt-Jakob disease (CJD). The interval from dural placement to clinical onset of CJD ranged from 16 months to nine years. Initial clinical presentation consisted of cerebellar symptoms, with dementia and myoclonus developing in later stages of the disease. EEGs showed diffuse slowing that evolved to a periodic activity pattern. CT and MRI were unremarkable in the early stages but pronounced cerebral and cerebellar atrophy with widened sulci and collections of fluid over the convexities were seen in the late stages of disease. The diagnosis was histologically proved by brain biopsy in all four cases. Molecular genetic analysis showed that the four patients were homozygous for methionine at codon 129 of the PrP gene. From this experience, and from six previous descriptions of this occurrence in the literature, it is manifest that awareness of the means of iatrogenic transmission of CJD, and the adoption of preventive measures, constitute the only effective way to stop the spread of CJD among patients who have neurosurgery.

Full text

PDF
1094

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernoulli C., Siegfried J., Baumgartner G., Regli F., Rabinowicz T., Gajdusek D. C., Gibbs C. J., Jr Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet. 1977 Feb 26;1(8009):478–479. doi: 10.1016/s0140-6736(77)91958-4. [DOI] [PubMed] [Google Scholar]
  2. Brown P., Cathala F., Raubertas R. F., Gajdusek D. C., Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology. 1987 Jun;37(6):895–904. doi: 10.1212/wnl.37.6.895. [DOI] [PubMed] [Google Scholar]
  3. Brown P., Cervenáková L., Goldfarb L. G., McCombie W. R., Rubenstein R., Will R. G., Pocchiari M., Martinez-Lage J. F., Scalici C., Masullo C. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology. 1994 Feb;44(2):291–293. doi: 10.1212/wnl.44.2.291. [DOI] [PubMed] [Google Scholar]
  4. Brown P., Gajdusek D. C., Gibbs C. J., Jr, Asher D. M. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med. 1985 Sep 19;313(12):728–731. doi: 10.1056/NEJM198509193131205. [DOI] [PubMed] [Google Scholar]
  5. Brown P., Gibbs C. J., Jr, Amyx H. L., Kingsbury D. T., Rohwer R. G., Sulima M. P., Gajdusek D. C. Chemical disinfection of Creutzfeldt-Jakob disease virus. N Engl J Med. 1982 May 27;306(21):1279–1282. doi: 10.1056/NEJM198205273062107. [DOI] [PubMed] [Google Scholar]
  6. Brown P. Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts. Pediatrics. 1988 Jan;81(1):85–92. [PubMed] [Google Scholar]
  7. Brown P., Preece M. A., Will R. G. "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet. 1992 Jul 4;340(8810):24–27. doi: 10.1016/0140-6736(92)92431-e. [DOI] [PubMed] [Google Scholar]
  8. Cochius J. I., Burns R. J., Blumbergs P. C., Mack K., Alderman C. P. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust N Z J Med. 1990 Aug;20(4):592–593. doi: 10.1111/j.1445-5994.1990.tb01322.x. [DOI] [PubMed] [Google Scholar]
  9. Diringer H., Braig H. R. Infectivity of unconventional viruses in dura mater. Lancet. 1989 Feb 25;1(8635):439–440. doi: 10.1016/s0140-6736(89)90035-4. [DOI] [PubMed] [Google Scholar]
  10. Duffy P., Wolf J., Collins G., DeVoe A. G., Streeten B., Cowen D. Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med. 1974 Mar 21;290(12):692–693. [PubMed] [Google Scholar]
  11. Fradkin J. E., Schonberger L. B., Mills J. L., Gunn W. J., Piper J. M., Wysowski D. K., Thomson R., Durako S., Brown P. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA. 1991 Feb 20;265(7):880–884. [PubMed] [Google Scholar]
  12. Gaches J., Supino-Viterbo V., Oughourlian J. M. Unusual electroencephalographic and clinical evolution of a case of meningioma of the left temporo-occipital convexity. Eur Neurol. 1971;5(3):155–164. doi: 10.1159/000114067. [DOI] [PubMed] [Google Scholar]
  13. Gajdusek D. C., Gibbs C. J., Jr, Asher D. M., Brown P., Diwan A., Hoffman P., Nemo G., Rohwer R., White L. Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med. 1977 Dec 8;297(23):1253–1258. doi: 10.1056/NEJM197712082972304. [DOI] [PubMed] [Google Scholar]
  14. Gottesdiener K. M. Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med. 1989 Jun 15;110(12):1001–1016. doi: 10.7326/0003-4819-110-12-1001. [DOI] [PubMed] [Google Scholar]
  15. Harries-Jones R., Knight R., Will R. G., Cousens S., Smith P. G., Matthews W. B. Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry. 1988 Sep;51(9):1113–1119. doi: 10.1136/jnnp.51.9.1113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Martínez-Lage J. F., Sola J., Poza M., Esteban J. A. Pediatric Creutzfeldt-Jakob disease: probable transmission by a dural graft. Childs Nerv Syst. 1993 Jul;9(4):239–242. doi: 10.1007/BF00303577. [DOI] [PubMed] [Google Scholar]
  17. Masullo C., Pocchiari M., Macchi G., Alema G., Piazza G., Panzera M. A. Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. J Neurosurg. 1989 Dec;71(6):954–955. doi: 10.3171/jns.1989.71.6.0954. [DOI] [PubMed] [Google Scholar]
  18. Matthews W. B. Epidemiology of Creutzfeldt-Jakob disease in England and Wales. J Neurol Neurosurg Psychiatry. 1975 Mar;38(3):210–213. doi: 10.1136/jnnp.38.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Miyashita K., Inuzuka T., Kondo H., Saito Y., Fujita N., Matsubara N., Tanaka R., Hinokuma K., Ikuta F., Miyatake T. Creutzfeldt-Jakob disease in a patient with a cadaveric dural graft. Neurology. 1991 Jun;41(6):940–941. doi: 10.1212/wnl.41.6.940. [DOI] [PubMed] [Google Scholar]
  20. NEVIN S., McMENEMEY W. H., BEHRMAN S., JONES D. P. Subacute spongiform encephalopathy--a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). Brain. 1960 Dec;83:519–564. doi: 10.1093/brain/83.4.519. [DOI] [PubMed] [Google Scholar]
  21. Prusiner S. B. Genetic and infectious prion diseases. Arch Neurol. 1993 Nov;50(11):1129–1153. doi: 10.1001/archneur.1993.00540110011002. [DOI] [PubMed] [Google Scholar]
  22. Tange R. A., Troost D., Limburg M. Progressive fatal dementia (Creutzfeldt-Jakob disease) in a patient who received homograft tissue for tympanic membrane closure. Eur Arch Otorhinolaryngol. 1990;247(4):199–201. doi: 10.1007/BF00178983. [DOI] [PubMed] [Google Scholar]
  23. Thadani V., Penar P. L., Partington J., Kalb R., Janssen R., Schonberger L. B., Rabkin C. S., Prichard J. W. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. J Neurosurg. 1988 Nov;69(5):766–769. doi: 10.3171/jns.1988.69.5.0766. [DOI] [PubMed] [Google Scholar]
  24. Will R. G., Matthews W. B. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 1982 Mar;45(3):235–238. doi: 10.1136/jnnp.45.3.235. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES